Kronox Lab Sciences Limited (KRONOX)
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 - Receipt of Draft Letter of Offer (DLOF) for Open Offer
Open Offer by Indo Borax and Chemicals Ltd (Acquirer) with Zenrock Chemicals Pvt Ltd (PAC) to acquire up to 95.7 million shares (25.79% voting capital) of Kronox Lab Sciences Ltd at ₹157.27/share. Offer follows SPA to acquire 64.26% shares from promoters at ₹103.22/share plus consultancy fees. Tendering period: Oct 15-29, 2026. Offer is mandatory under SEBI SAST Regulations. Acquirer to become promoter post acquisition; sellers to be reclassified as public. No minimum acceptance condition. Financial arrangements and approvals in place. Tax and procedural details provided.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 KRONOX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add KRONOX to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Kronox Lab Sciences Limited
Important.
The summary above is generated automatically from Kronox Lab Sciences Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.